相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
David S. Geldmacher et al.
ARCHIVES OF NEUROLOGY (2011)
Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy
Li Qian et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Effects of pioglitazone on diffusion tensor imaging indices in multiple sclerosis patients
Dinesh K. Shukla et al.
NEUROSCIENCE LETTERS (2010)
Beyond Access vs. Protection in Trials of Innovative Therapies
Alex John London et al.
SCIENCE (2010)
A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis
Claudia C. Kaiser et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Long-term Outcome of Early Versus Delayed Rasagiline Treatment in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2009)
Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF
M. E. Emborg et al.
NEUROBIOLOGY OF DISEASE (2009)
The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
L. P. Quinn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
PPAR: a therapeutic target in Parkinson's disease
Rajnish K. Chaturvedi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Contributions of non-human primates to neuroscience research
John P. Capitanio et al.
LANCET (2008)
Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats
Randy L. Hunter et al.
NEUROSCIENCE LETTERS (2008)
Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure
Taishi Nakamura et al.
STROKE (2007)
A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies
Madusha Peiris et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Effect of pioglitazone treatment on behavioral symptoms in autistic children
Marvin Boris et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system
Randy L. Hunter et al.
JOURNAL OF NEUROCHEMISTRY (2007)
High-performance liquid chromatographic method for the determination of pioglitazone in human plasma using ultraviolet detection and its application to a pharmacokinetic study
Pattana Sripalakit et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Ameliorative effect of pioglitazone on seizure responses in genetically epilepsy-susceptible EL mice
Kazumasa Okada et al.
BRAIN RESEARCH (2006)
Basal ganglia lesions after MPTP administration in rhesus monkeys
M. E. Emborg et al.
NEUROBIOLOGY OF DISEASE (2006)
The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice
B Schütz et al.
JOURNAL OF NEUROSCIENCE (2005)
Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
DL Feinstein et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives
S Mandel et al.
BRAIN RESEARCH REVIEWS (2005)
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure
C Barcia et al.
GLIA (2004)
Evaluation of animal models of Parkinson's disease for neuroprotective strategies
ME Emborg
JOURNAL OF NEUROSCIENCE METHODS (2004)
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration
PL McGeer et al.
ANNALS OF NEUROLOGY (2003)
Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
T Breidert et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2
EJ Kim et al.
BRAIN RESEARCH (2002)
Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients
Y Miyazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Peroxisome proliferator-activated receptor-γ agonists prevent experimental autoimmune encephalomyelitis
DL Feinstein et al.
ANNALS OF NEUROLOGY (2002)
Peroxisome proliferator-activated receptors in inflammation control
P Delerive et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
JH Kordower et al.
SCIENCE (2000)